MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 137 filers reported holding MERSANA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $346,716 | -66.5% | 273,005 | -13.2% | 0.00% | – |
| Q2 2023 | $1,034,649 | +357.8% | 314,483 | +841.1% | 0.00% | – |
| Q3 2022 | $226,000 | -67.6% | 33,416 | -80.9% | 0.00% | – |
| Q1 2022 | $698,000 | +6.6% | 175,021 | +66.0% | 0.00% | – |
| Q4 2021 | $655,000 | -29.0% | 105,423 | +7.8% | 0.00% | – |
| Q3 2021 | $922,000 | +29.5% | 97,832 | +86.8% | 0.00% | – |
| Q2 2021 | $712,000 | -30.5% | 52,372 | -17.3% | 0.00% | -100.0% |
| Q1 2021 | $1,025,000 | -87.8% | 63,335 | -79.9% | 0.00% | -75.0% |
| Q4 2020 | $8,404,000 | +636.5% | 315,820 | +415.7% | 0.00% | – |
| Q3 2020 | $1,141,000 | -72.1% | 61,243 | -65.0% | 0.00% | -100.0% |
| Q2 2020 | $4,090,000 | +5580.6% | 174,778 | +1310.5% | 0.00% | – |
| Q1 2020 | $72,000 | -71.1% | 12,391 | -79.8% | 0.00% | – |
| Q2 2019 | $249,000 | +315.0% | 61,459 | +441.7% | 0.00% | – |
| Q1 2019 | $60,000 | – | 11,346 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |